Research ExplorerPublicationsMedikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infekt...

Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?

Standard

Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was? / Sensen, Barbara; Wichmann, Dominic; Kluge, Stefan.

In: PNEUMOLOGIE, Vol. 77, No. 1, 01.2023, p. 21-26.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Sensen, B, Wichmann, D & Kluge, S 2023, 'Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?', PNEUMOLOGIE, vol. 77, no. 1, pp. 21-26. https://doi.org/10.1055/a-1983-3800

APA

Sensen, B., Wichmann, D., & Kluge, S. (2023). Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was? PNEUMOLOGIE, 77(1), 21-26. https://doi.org/10.1055/a-1983-3800

Vancouver

Sensen B, Wichmann D, Kluge S. Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was? PNEUMOLOGIE. 2023 Jan;77(1):21-26. https://doi.org/10.1055/a-1983-3800

Bibtex

@article{244fa8d273db43388451f9ebddffb39f,
title = "Medikament{\"o}se Therapiema{\ss}nahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?",
abstract = "There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline {"}Recommendations for inpatient therapy of patients with COVID-19{"} provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.",
keywords = "Humans, COVID-19, SARS-CoV-2, Risk Factors, Contraindications",
author = "Barbara Sensen and Dominic Wichmann and Stefan Kluge",
note = "Thieme. All rights reserved.",
year = "2023",
month = jan,
doi = "10.1055/a-1983-3800",
language = "Deutsch",
volume = "77",
pages = "21--26",
journal = "PNEUMOLOGIE",
issn = "0934-8387",
publisher = "Georg Thieme Verlag KG",
number = "1",

}

RIS

TY - JOUR

T1 - Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?

AU - Sensen, Barbara

AU - Wichmann, Dominic

AU - Kluge, Stefan

N1 - Thieme. All rights reserved.

PY - 2023/1

Y1 - 2023/1

N2 - There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline "Recommendations for inpatient therapy of patients with COVID-19" provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.

AB - There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline "Recommendations for inpatient therapy of patients with COVID-19" provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.

KW - Humans

KW - COVID-19

KW - SARS-CoV-2

KW - Risk Factors

KW - Contraindications

U2 - 10.1055/a-1983-3800

DO - 10.1055/a-1983-3800

M3 - Andere (Vorworte u.ä.)

C2 - 36691378

VL - 77

SP - 21

EP - 26

JO - PNEUMOLOGIE

JF - PNEUMOLOGIE

SN - 0934-8387

IS - 1

ER -